Guia Covid-19

Public health

RETROSPECT

The shadow of the white plague

Tuberculosis persists, even 100 years after its vaccine was invented

By

Interview

Linamara Rizzo Battistella: In defense of movement

The physician who helped establish Brazil's policy on the rights of people with disabilities now fights to rehabilitate Covid-19 patients

By and

COVID-19

Severe illness in children

A rare syndrome linked to the novel coronavirus causes lesions in multiple organs

By

COVID-19

Focus on the genome

Brazil is still behind in monitoring Sars-CoV-2 genetics, but an injection of funding for research networks and the acquisition of materials could improve the situation

By

COVID-19

Risk of death is higher among the poor in Chile

People under 40 living in poorer municipalities in the Metropolitan Region of Santiago, Chile, are 3.1 times more likely to die from complications associated with COVID-19 than those who live in more affluent regions

By

COVID-19

Lasting consequences

People who survive SARS-CoV-2, even those not hospitalized, can suffer the effects of the infection for months after the most intense symptoms subside

By

COVID-19

The virus and the loss of smell

The loss of smell that affects up to two-thirds of people infected with SARS-CoV-2 is a consequence of both the direct action of the virus and the inflammation it triggers in the olfactory system, according to a team of researchers

By

COVID-19

Dengue increases risk of COVID-19 symptoms

The risk of developing COVID-19 symptoms when infected with the novel coronavirus is twice as high among individuals who have had dengue in the past

By

Covid-19

Mask effectiveness tests

Researchers compared the quality of 227 types of face masks sold in Brazil, measuring their ability to block the novel coronavirus

By

COVID-19

All eyes on ButanVac

New vaccine candidate uses a more stable version of the spike protein

By

COVID-19

Patent waivers under debate

Suspending intellectual property rights for vaccines needs to overcome technology and production hurdles if it is to be successful

By

COVID-19

New clues about blood clots linked to the AstraZeneca vaccine

A step has been taken towards explaining why the vaccine developed by the pharmaceutical company AstraZeneca can very rarely lead to the formation of blood clots

By

COVID-19

The months-long consequences of COVID-19

The long-term effects of COVID-19 are becoming clearer

By

COVID-19

The importance of the cellular response against the coronavirus

Fighting a SARS-CoV-2 infection is not solely the responsibility of antibodies, the proteins that adhere to the virus’s surface to prevent it from entering cells or mark it for destruction

By

COVID-19

Superior immunity

Studies of blood and tissue samples taken before the COVID-19 pandemic may help explain why the disease is more common and more severe in adults than in children

By

Public health

Tuberculosis in prisons

Tuberculosis cases in the Latin American prison population increased by 269% between 2011 and 2017

By

Public administration

Crafting healthcare policy

Since the 1970s, researchers and other actors have worked to integrate government, science, and the economy in the health-industry complex

By

Public health

An agenda for forgotten diseases

WHO launches road map to 2030 for preventing and eradicating neglected tropical diseases

By

COVID-19

Complex choices

Bioethics committees have become increasingly important in solving dilemmas brought about by the pandemic, but few hospitals have them

By

COVID-19

A town turned laboratory

Epidemiological studies, such as the one led in the town of Serrana, São Paulo, should provide valuable information about the pandemic

By

COVID-19

New vaccines on the way

Butantan Institute and federal government plan to start human trials of two vaccine candidates in the coming months

By and

COVID-19

The evolution of a virus

Low vaccination rates and lack of control over SARS-CoV-2 circulation is increasing the likelihood that more transmissible and lethal variants will emerge

By

COVID-19

High infant mortality in Sergipe

Despite having enough beds available in intensive care units (ICU) for adults, Sergipe has a 41% shortfall in pediatric beds

By

nuclear tests

France underestimated how many were affected by nuclear testing

The inhabitants of the archipelagos of French Polynesia were exposed to 2–20 times more radiation than previously estimated

By

Covid-19

Poor performance

Brazil's response to the pandemic was considered the worst in the world by a survey released in January by the Lowy Institute, Australia

By

Retrospect

Open pathways to the first vaccine

The techniques and concepts used to eradicate smallpox in Brazil 50 years ago are still applied today to contain epidemics

By

INTERVIEW

Eurico Arruda: Admirer of viruses

Coronavirus specialist and USP physician speaks about the new variants of SARS-CoV-2 and the risk they represent in the efficacy of some vaccines

By

Covid-19

The expected effect of vaccines

Administering vaccines on a large scaled will tell us whether, in addition to protecting against the disease, they are also able to prevent infection by SARS-CoV-2

By

Covid-19

Breathless emerging economies

Lack of public and private investment heightens the dependence of Brazil and South Africa on vaccines from other countries, unlike the other BRICS members

By

Covid-19

Obstacle course

Research centers working on vaccines for the novel coronavirus in Brazil face major hurdles

By